AstraZeneca Vaccine Cleared for Emergency Use in Indonesia
- Residents older than 18 years old to get AstraZeneca vaccine
- Drug regulator BPOM is assessing approval for Moderna shot
This article is for subscribers only.
Follow Bloomberg on LINE messenger for all the business news and analysis you need.
Indonesia cleared AstraZeneca Plc’s coronavirus vaccine for emergency use, a second shot made available by the government to bolster its inoculation drive amid concern over an influx of new virus variants.